Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma

Current prenatal diagnosis for fetal aneuploidies (including trisomy 21 [T21]) generally relies on an initial biochemical serum-based noninvasive prenatal testing (NIPT) after which women who are deemed to be at high risk are offered an invasive confirmatory test (amniocentesis or chorionic villi sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gekas, Jean, Langlois, Sylvie, Ravitsky, Vardit, Audibert, François, van den Berg, David-Gradus, Haidar, Hazar, Rousseau, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104725/
https://www.ncbi.nlm.nih.gov/pubmed/25053891
http://dx.doi.org/10.2147/TACG.S35602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104725/
https://www.ncbi.nlm.nih.gov/pubmed/25053891
http://dx.doi.org/10.2147/TACG.S35602

Ejemplares similares